Your browser doesn't support javascript.
loading
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer.
Yoder, Rachel; Kimler, Bruce F; Staley, Joshua M; Schwensen, Kelsey; Wang, Yen Y; Finke, Karissa; O'Dea, Anne; Nye, Lauren; Elia, Manana; Crane, Gregory; McKittrick, Richard; Pluenneke, Robert; Madhusudhana, Sheshadri; Beck, Larry; Shrestha, Anuj; Corum, Larry; Marsico, Mark; Stecklein, Shane R; Godwin, Andrew K; Khan, Qamar J; Sharma, Priyanka.
Afiliação
  • Yoder R; University of Kansas Cancer Center, Kansas City, KS, USA.
  • Kimler BF; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Staley JM; University of Kansas Cancer Center, Kansas City, KS, USA.
  • Schwensen K; Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS, USA.
  • Wang YY; University of Kansas Cancer Center, Kansas City, KS, USA.
  • Finke K; Clinical Trials Shared Resource, University of Kansas Medical Center, Westwood, KS, USA.
  • O'Dea A; Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS, USA.
  • Nye L; Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS, USA.
  • Elia M; Department of Internal Medicine, University of Kansas Medical Center, Lee's Summit, MO, USA.
  • Crane G; Department of Internal Medicine, University of Kansas Medical Center, Overland Park, KS, USA.
  • McKittrick R; Department of Internal Medicine, University of Kansas Medical Center, Overland Park, KS, USA.
  • Pluenneke R; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, MO, USA.
  • Madhusudhana S; Department of Internal Medicine, University of Missouri-Kansas City, Kansas City, MO, USA.
  • Beck L; Tammy Walker Cancer Center, Salina Regional Health Center, Salina, KS, USA.
  • Shrestha A; Richard & Annette Bloch Cancer Center, Truman Medical Center, Kansas City, MO, USA.
  • Corum L; Olathe Cancer Care, Olathe Medical Center, Olathe, KS, USA.
  • Marsico M; Department of Pharmacoepidemiology/Oncology, Merck & Co., Inc, Kenilworth, NJ, USA.
  • Stecklein SR; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Godwin AK; University of Kansas Cancer Center, Kansas City, KS, USA.
  • Khan QJ; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
  • Sharma P; Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS, USA.
NPJ Breast Cancer ; 8(1): 80, 2022 Jul 11.
Article em En | MEDLINE | ID: mdl-35817765
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article